[1]
A. Keshandehghan, A. Rostamian Tabari, Y. Panahi, and M. Gardaneh, “Acquisition of Doxorubicin Resistance Induces Breast Cancer Cell Migration and Epithelial-Mesenchymal Transition that are Reversed by Shikonin-Metformin Synergy: Dox resistance and BC cell migration”, Arch Breast Cancer, vol. 11, no. 2, pp. 159–171, May 2024.